Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

46.56

-1.57 (-3.26%)

At close: Feb 5, 2026, 4:00 PM EST

46.60

+0.02 (0.04%)

Pre-market: Feb 6, 2026, 5:55 AM EST

Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,012	645	154	-	-
Market Cap Growth	200.07%	318.69%	-	-	-
Enterprise Value	1,459	364	-35	-	-
Last Close Price	46.58	21.80	10.40	-	-
PS Ratio	654.10	103.48	54.53	-	-
PB Ratio	3.65	1.83	0.91	-	-
P/TBV Ratio	3.68	1.83	0.91	-	-
EV/Sales Ratio	474.05	58.45	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	-
Asset Turnover	0.01	0.02	0.02	0.14	-
Quick Ratio	17.09	14.96	18.09	9.86	1.70
Current Ratio	17.35	15.22	18.43	9.97	1.75
Return on Equity (ROE)	-28.57%	-32.60%	-35.92%	-73.25%	-
Return on Assets (ROA)	-18.82%	-23.01%	-22.94%	-40.12%	-
Return on Capital Employed (ROCE)	-25.30%	-28.60%	-28.40%	-39.70%	-319.20%
Earnings Yield	-6.28%	-13.17%	-28.26%	-	-
FCF Yield	-5.45%	-12.13%	-23.99%	-	-
Buyback Yield / Dilution	-28.44%	-546.44%	-489.48%	78.17%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q